Fatty liver disease

Since I learned I’d become a full-fledged metabolic dysfunction-associated steatohepatitis (MASH) patient, I’ve collected an assortment of friends with different medical issues. One of…

As part of a merger deal, Roche will acquire 89bio and its treatment candidate pegozafermin — an injection therapy now being tested in two global…

I enjoy listening to the sounds of the city outside my bedroom window at night. Cars hum down the thoroughfare where I live, their headlights…

The U.S. Food and Drug Administration (FDA) will evaluate the use of Fibroscan, a noninvasive test, to replace liver biopsies in clinical trials for metabolic…

For as long as I can remember, I’ve dreaded visiting the dentist. It started in childhood with a mean dentist who’d once had his thumb…

Exposure to excessive alcohol disrupts the activity of a protein that plays a key role in keeping liver fat healthy, a study found. Researchers said…

I have mixed feelings as summer begins to pack up shop for the year. This season has a certain energy, like a house party with…

My daughter has never asked much about my health, let alone how I live with metabolic dysfunction-associated steatohepatitis (MASH). I don’t expect her to…

Regulators in the European Union (EU) have granted conditional approval to Rezdiffra (resmetirom) for some people with metabolic dysfunction-associated steatohepatitis (MASH), making it the first…

The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with metabolic dysfunction-associated steatohepatitis (MASH), a…